Clincosm LogoSign in Get a demo

Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic

Sponsor
M.D. Anderson Cancer Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05102656
Collaborator
(none)
106
Enrollment
1
Location
19
Anticipated Duration (Months)
5.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study investigates patients' perceptions of their doctor's or nurse's empathy during an in-person interaction with the doctor or nurse wearing personal protective equipment (PPE) compared to during a video interaction with the doctor or nurse without PPE. The goal of this research study is to learn whether patients who visit the Acute Cancer Care Center at MD Anderson believe they get better (more empathetic) care from doctors who visit them in person wearing PPE or from doctors who visit them by video call and do not wear PPE.

Condition or Disease Intervention/Treatment Phase
  • Other: Best Practice
  • Procedure: Discussion
  • Other: Questionnaire Administration

Detailed Description

PRIMARY OBJECTIVE:
  1. To determine whether patients perceive their healthcare practitioner as more empathetic during an in-person interaction with the practitioner wearing personal protective equipment (PPE), or during a video interaction without the need for PPE.
SECONDARY OBJECTIVES:

  1. To assess whether certain physicians perform better with video whereas others perform better in person.

  2. To characterize generational differences in patient perception of healthcare practitioner empathy during an in person interaction with the practitioner wearing PPE, or during a video interaction without the need for PPE.

OUTLINE: After initial visit, patients are randomized to 1 of 2 groups.

GROUP A (NO PPE): Patients receive standard of care via video call with treating physician.

GROUP B (WEARING PPE): Patients receive standard of care in-person physician visits.

Study Design

Study Type:
Observational
Anticipated Enrollment :
106 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During COVID-19: A Randomized, Controlled Trial Comparing In-Person Interaction With Personal Protective Equipment (PPE) Versus Video Interaction Without PPE
Actual Study Start Date :
Jun 2, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Group A (video call)

Patients receive standard of care via video call with treating physician.

Procedure: Discussion
Physician conversations occur via video call
Other Names:
  • Discuss

    • Other: Questionnaire Administration
    Ancillary studies
    Group B (in-person)

    Patients receive standard of care in-person physician visits.

    Other: Best Practice
    Physician conversations occur in-person
    Other Names:
  • standard of care
  • standard therapy

    • Other: Questionnaire Administration
    Ancillary studies

    Outcome Measures

    Primary Outcome Measures

    1. Patients' perceptions of healthcare provider empathy [Through study completion, an average of 1 year]

      Univariate linear regression analysis will be used to determine the association between the approach (in-person interaction/with personal protective equipment [PPE] versus video interaction/without PPE) and the composite scores or scores for each question (for each of the two tools [the CARE Measure and the linear empathy tool]).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • = 18 years old

    • Able to speak and write in English

    • Able to understand and willing to sign a written informed consent document

    • Willing and able to complete the study assessment(s)

    Exclusion Criteria:

    • Refuses to participate

    • Too ill to participate, in the estimation of the patient's physician

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 M D Anderson Cancer Center Houston Texas United States 77030

    Sponsors and Collaborators

    • M.D. Anderson Cancer Center

    Investigators

    • Principal Investigator: Kumar Alagappan, M.D. Anderson Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    M.D. Anderson Cancer Center
    ClinicalTrials.gov Identifier:
    NCT05102656
    Other Study ID Numbers:
    • 2020-1298
    • NCI-2021-10960
    • 2020-1298
    First Posted:
    Nov 1, 2021
    Last Update Posted:
    Jan 31, 2022
    Last Verified:
    Jan 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    COVID-19
    Neoplasms
    Emergencies

    Study Results

    No Results Posted as of Jan 31, 2022